Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Definition: Orthopedics 10
1.3 Healthcare Spending in the US 12
1.4 Reimbursement Scenario 12
1.5 Emerging Global Markets 13
1.6 Musculoskeletal disorders 14
1.6.1 Knee Implants 16
1.6.2 Hip Implants 16
1.6.3 Ankle & Foot Implants 16
1.6.4 Shoulder Implants 16
1.6.5 Spine Implants 16
1.6.6 Trauma Fixation Devices 16
1.6.7 Sports Medicine Devices 17
1.6.8 Orthobiologics 17
1.7 Industry Trends 17
1.8 PEST Analysis 18
2 Report Outline 19
2.1 Report Scope 19
2.2 Report Summary 19
2.3 Research Methodology 20
2.4 Report Assumptions 20
3 Market Snapshot 21
3.1 Total Addressable Market (TAM) 21
3.2 Segmented Addressable Market (SAM) 22
3.2.1 Overview 22
3.2.2 Total hip replacement implant 24
3.2.3 Partial hip replacement implant 24
3.2.4 Revision hip replacement implant 25
3.2.5 Hip resurfacing 25
3.3 Related Markets 25
3.3.1 Surgical Devices Market 25
3.3.2 Biomaterial Market 26
3.3.3 Dental Implant Market 26
3.3.4 Energy-based Aesthetic Devices Market 26
3.3.5 Spine Orthopedic Devices Market 26
4 Market Outlook 26
4.1 Overview 27
4.2 Importance of Hip Implants 27
4.3 Porter 5(Five) Forces 27
5 Market Characteristics 29
5.1 Evolution 29
5.2 DRO - Global Hip Replacement Implant Market Dynamics 31
5.2.1 Drivers 32
5.2.1.1 Rise in the prevalence of osteoporosis 32
5.2.1.2 Increasing popularity of total hip arthroplasty 33
5.2.1.3 Growing popularity of minimally invasive surgeries 33
5.2.1.4 Rise in elderly population 33
5.2.1.5 Increase in the number of outpatient procedures 34
5.2.2 Opportunities 34
5.2.2.1 Technological advancements 34
5.2.2.2 Increased usage of orthopedic biomaterials 34
5.2.2.1 Increase in healthcare spending 35
5.2.2.2 Increase in mergers & acquisitions 35
5.2.3 Restraints 36
5.2.3.1 Complications and risks associated with hip implant procedures 36
5.2.3.2 High cost of hip replacement procedures 36
5.2.3.3 Stringent regulatory framework and labeling requirement 37
5.2.3.4 Poor reimbursement policies 37
5.2.3.5 Intense competition among vendors 37
5.2.4 DRO - Impact Analysis 37
5.2.5 Key Stakeholders 38
6 Types: Market Size and Analysis 40
6.1 Overview 40
6.2 Total Hip Replacement 42
6.2.1 Overview 42
6.3 Partial Hip Replacement 44
6.3.1 Overview 44
6.4 Revision Hip Replacement 45
6.4.1 Overview 45
6.5 Hip Resurfacing 46
6.5.1 Overview 46
7 End-user: Market Size and Analysis 49
7.1 Overview 49
7.2 Hospitals 49
7.3 Ambulatory Care 50
7.4 Trauma Centers 50
8 Regions: Market Size and Analysis 52
8.1 Overview 52
8.2 North America 54
8.2.1 Market Overview 54
8.3 Europe 55
8.3.1 Market Overview 56
8.4 APAC 57
8.4.1 Market Overview 58
8.5 Rest of the World 59
8.5.1 Market Overview 60
9 Competitive Landscape 63
9.1 Overview 63
10 Vendor Profiles 64
10.1 Johnson & Johnson (DePuy Synthes' Inc) 64
10.1.1 Overview 64
10.1.2 Business Unit 68
10.1.3 Geographic Presence 69
10.1.4 Business Focus 70
10.1.5 SWOT Analysis 71
10.1.6 Business Strategy 71
10.2 Stryker Corp. 72
10.2.1 Overview 72
10.2.2 Business Unit 75
10.2.3 Geographic Revenue 76
10.2.4 Business Focus 77
10.2.5 SWOT Analysis 78
10.2.6 Business Strategy 78
10.3 Smith & Nephew' Inc 80
10.3.1 Overview 80
10.3.2 Business Unit 83
10.3.3 Geographic Revenue 84
10.3.4 Business Focus 85
10.3.5 SWOT Analysis 85
10.3.6 Business Strategy 86
10.4 Zimmer Biomet Holdings' Inc 87
10.4.1 Overview 87
10.4.2 Business Unit 90
10.4.3 Geographic Revenue 91
10.4.4 Business Focus 92
10.4.5 SWOT Analysis 92
10.4.6 Business Strategy 93
11 Companies to Watch For 94
11.1 Arthrex 94
11.1.1 Overview 94
11.1.2 Key Highlights 94
11.1.3 Business Strategies 94
11.2 Orthofix International N.V. 94
11.2.1 Key Highlights 95
11.2.2 Business Strategies 95
11.3 B. Braun 96
11.3.1 Overview 96
11.3.2 Key Highlights 96
11.3.3 Business Strategies 96
11.4 Wright Medical Group N.V. 96
11.4.1 Overview 96
11.5 OMNIlife Science 97
11.5.1 Overview 97
Annexure 97
Abbreviations 98